Luke Evnin, PhD

Dr. Luke Evnin is a general partner at MPM Capital. Before joining MPM, Dr. Evnin was at Accel Partners for over seven years including four years as a general partner. He was involved in biopharmaceutical, pharmaceutical, medical device, and health-care service companies for Accel's Funds III, IV, and V. He was responsible for health-care investment strategy, deal origination, analyses, investment, and gain realization. Dr. Evnin began his career in the field of science. He earned his PhD in the Department of Biochemistry at the University of California-San Francisco, and he received his AB in Molecular Biology magna cum laude from Princeton University. Dr. Evnin is currently director of BioValve, Intercell, Metabasis, Oscient, Peptimmune, Restore Medical, and Venturi Group. He was previously a director at Atugen, CHF Solutions, Medical SelfCare, Sonic Innovations, Epic Therapeutics, EPIX Medical, and several other private companies.